Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to test the efficacy of remedial cognitive intervention using The Functional Brain Trainer VR (FBT, Intendo ©) to improve cognitive functioning, participation in daily life occupations, and functional capacity in the field of IADL among people with affective disorders receiving inpatient and daycare mental-health services.


Clinical Trial Description

This study is an experimental study, in a pre-post design with a control group, the sampling is convenience. The study will include 40 people aged 18-60 with a diagnosis of Affective disorder based on DSM-5.

Inclusion criteria: age 18-60, Diagnosis of Major Depression or Bipolar disorder based on DSM-5; Mood stabilizing medication for at least 2 weeks, Exclusion criteria: Neurological disorders and neurodevelopmental conditions in addition to mental health diagnosis; Physical disability in addition to mental health conditions; Psychotic state; active substance abuse; custodian.

They will be recruited from active inpatient and daycare wards of the "Geha Mental Health Center", Israel and will be randomly allocated into two groups: experimental and control. An experimental group will attend 6 VR based cognitive remediation sessions of 30 minutes for training response inhibition, self-initiation, cognitive flexibility, sustained attention, divided attention, working memory, planning, persistence. The control group will complete 6 sessions of 30 minutes of low-tech (paper and pencil tasks) remedial training of the same cognitive components. These in addition to routine care. The evaluation for symptoms severity, cognition, functional capacity and participation in daily life activities will be conducted at the beginning of the study and after about 4 weeks. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04288609
Study type Interventional
Source Geha Mental Health Center
Contact Gilad Eger, PhD
Phone +972523520180
Email giladeg1@clalit.org.il
Status Not yet recruiting
Phase N/A
Start date March 2020
Completion date December 1, 2020

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04136054 - Better Sleep in Psychiatric Care - Anxiety and Affective Disorders N/A
Recruiting NCT05461885 - Value of Gym-based Exercise Training for Young Adults Receiving Antipsychotic Medication: The Vega Trial N/A
Completed NCT01721824 - The Effect of IPS-MA- A Modified Early Supported Employment Intervention for Individuals With Mood or Anxiety Disorders N/A
Recruiting NCT05869409 - Physical Activity, Psychopathology, and Quality of Life in People With Psychotic or Affective Disorders
Active, not recruiting NCT05249309 - Naturalistic Study of Ketamine in the Treatment of Depression
Completed NCT03235908 - Copeptin in Outcome Prediction of an Acute Psychotic Episode
Recruiting NCT03294525 - Towards Neurobiology-based Diagnosis and Treatment of Affective Disorders
Completed NCT04489641 - Brief Group Psychotherapy for Anxiety and Depression N/A
Recruiting NCT05596461 - New Techniques for Diagnosis and Treatment of Cognitive Impairment in Affective Disorder N/A
Completed NCT03609515 - Patient-controlled Admissions in Inpatient Mental Health Services N/A